I just received an email question about whether multiple myeloma survivors should be eating asparagus. So I referred back to a column I wrote a year ago about it. I was surprised and pleased to note that 3,236 people had viewed that post. Pretty cool! I get too busy to keep track of such things.
The prestigious, well known mainstream publication, The Atlantic, included noted cancer research scientist, Harvard Medical School's Jay Bradner, as a part of their Brave Thinkers series. If you recall, Dr. Bradner has been working on the potentially game changing anti-cancer compound, JQ1. Jay Bradner, Research Scientist, Harvard Medical School Two years ago, after Jay Bradner
Two weeks ago I re-visited the promising new anti-cancer therapy, JQ1, after learning that JQ1 may also hold the key to male contraception. If you haven't been following along, last summer a group of Dana-Farber Cancer Institute scientists reported that they had "successfully disrupted the function of a cancer gene involved in the formation of most